Company No:
Contents
| DIRECTORS | Anselm Marc Adams |
| David Hugh Clayton | |
| Steven Andrew Cliffe |
| REGISTERED OFFICE | Treviot House |
| 186-192 High Road | |
| Ilford | |
| IG1 1LR | |
| United Kingdom |
| COMPANY NUMBER | 10651231 (England and Wales) |
| ACCOUNTANT | Gravita Essex Limited |
| Treviot House | |
| 186-192 High Road | |
| Ilford | |
| Essex | |
| IG1 1LR | |
| United Kingdom |
| Note | 2025 | 2024 | ||
| £ | £ | |||
| Fixed assets | ||||
| Intangible assets | 4 |
|
|
|
| Tangible assets | 5 |
|
|
|
| Investments | 6 |
|
|
|
| 1,710,956 | 2,026,441 | |||
| Current assets | ||||
| Debtors | 7 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 163,646 | 36,804 | |||
| Creditors: amounts falling due within one year | 8 | (
|
(
|
|
| Net current liabilities | (1,158) | (159,058) | ||
| Total assets less current liabilities | 1,709,798 | 1,867,383 | ||
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital |
|
|
||
| Share premium account |
|
|
||
| Other reserves |
|
|
||
| Profit and loss account | (
|
(
|
||
| Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of Albora Technologies Limited (registered number:
|
Anselm Marc Adams
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Albora Technologies Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Treviot House, 186-192 High Road, Ilford, IG1 1LR, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.
Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.
Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of shares that will eventually vest and adjusted for the effect of non-market-based vesting conditions.
Fair value is measured by use of the [appropriate pricing] model which is considered by management to be the most appropriate method of valuation. The expected life used in the model has been adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and behavioural considerations.
Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
| Other intangible assets |
|
| Plant and machinery etc. |
|
|
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably.
Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.
Expenditure on research and development is written off in the year in which it is incurred.
| 2025 | 2024 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including directors |
|
|
Equity-settled share-based payment schemes
The company also operates multiple Unapproved Share Option Schemes. The options are granted with a fixed exercise price determined at the grant of the option. The options either vest 50% over a period of up to 4 years following the date of the grant with the remaining 50% vesting on an exit event, or options vest over a period of up to 5 years following the date of the grant and are only exercisable on exit. The options are exercisable until up to the 10th anniversary from the date of grant.
Details of the share options outstanding during the financial year are as follows:
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Weighted Average | Weighted Average | ||||
| Number of share options | Average exercise price (£) | Number of share options | Average exercise price (£) | ||
| Outstanding at beginning of period |
|
|
|
|
|
| Granted during the period |
|
|
|
|
|
| Forfeited during the period |
|
|
(
|
|
|
| Outstanding at the end of the period |
|
|
|
|
|
| Exercisable at the end of the period |
|
|
|
|
|
The Company recognised a credit of £200,682 related to equity-settled share-based payment transactions in 2025. In 2024 the Company recognised a charge £181,527.
| Other intangible assets | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2024 |
|
|
|
| At 31 March 2025 |
|
|
|
| Accumulated amortisation | |||
| At 01 April 2024 |
|
|
|
| Charge for the financial year |
|
|
|
| At 31 March 2025 |
|
|
|
| Net book value | |||
| At 31 March 2025 |
|
|
|
| At 31 March 2024 |
|
|
| Plant and machinery etc. | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2024 |
|
|
|
| At 31 March 2025 |
|
|
|
| Accumulated depreciation | |||
| At 01 April 2024 |
|
|
|
| Charge for the financial year |
|
|
|
| At 31 March 2025 |
|
|
|
| Net book value | |||
| At 31 March 2025 | 5,228 | 5,228 | |
| At 31 March 2024 | 9,754 | 9,754 |
| Other investments | Total | ||
| £ | £ | ||
| Cost or valuation before impairment | |||
| At 01 April 2024 |
|
|
|
| At 31 March 2025 |
|
|
|
| Provisions for impairment | |||
| At 01 April 2024 |
|
|
|
| Impairment |
|
|
|
| At 31 March 2025 |
|
|
|
| Carrying value at 31 March 2025 |
|
|
|
| Carrying value at 31 March 2024 |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Other debtors |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Trade creditors |
|
|
|
| Amounts owed to own subsidiaries |
|
|
|
| Other taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|